FR2583049B1 - Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits - Google Patents

Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits

Info

Publication number
FR2583049B1
FR2583049B1 FR8508769A FR8508769A FR2583049B1 FR 2583049 B1 FR2583049 B1 FR 2583049B1 FR 8508769 A FR8508769 A FR 8508769A FR 8508769 A FR8508769 A FR 8508769A FR 2583049 B1 FR2583049 B1 FR 2583049B1
Authority
FR
France
Prior art keywords
muramyl
peptide
products
haptena
saccharidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8508769A
Other languages
English (en)
Other versions
FR2583049A1 (fr
Inventor
Michel Jolivet
Francoise Audibert
Louis Chedid
Pierre Lefrancier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR8508769A priority Critical patent/FR2583049B1/fr
Priority to JP50315786A priority patent/JPS63500515A/ja
Priority to EP19860903429 priority patent/EP0224540A1/fr
Priority to PCT/FR1986/000201 priority patent/WO1986007365A1/fr
Publication of FR2583049A1 publication Critical patent/FR2583049A1/fr
Application granted granted Critical
Publication of FR2583049B1 publication Critical patent/FR2583049B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR8508769A 1985-06-10 1985-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits Expired FR2583049B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8508769A FR2583049B1 (fr) 1985-06-10 1985-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits
JP50315786A JPS63500515A (ja) 1985-06-10 1986-06-10 高分子支持体とハプテンとムラミルペプチドとをこのムラミルペプチドの糖質部分で置換する基を介して互いに結合させることにより得られる生成物、及び該生成物を含む選択的免疫原性組成物
EP19860903429 EP0224540A1 (fr) 1985-06-10 1986-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide.
PCT/FR1986/000201 WO1986007365A1 (fr) 1985-06-10 1986-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8508769A FR2583049B1 (fr) 1985-06-10 1985-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits

Publications (2)

Publication Number Publication Date
FR2583049A1 FR2583049A1 (fr) 1986-12-12
FR2583049B1 true FR2583049B1 (fr) 1988-08-05

Family

ID=9320073

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8508769A Expired FR2583049B1 (fr) 1985-06-10 1985-06-10 Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits

Country Status (4)

Country Link
EP (1) EP0224540A1 (fr)
JP (1) JPS63500515A (fr)
FR (1) FR2583049B1 (fr)
WO (1) WO1986007365A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4284537A (en) * 1980-07-03 1981-08-18 The United States Of America As Represented By The Department Of Health And Human Services Conjugate of streptococcal M protein peptide vaccine
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins

Also Published As

Publication number Publication date
EP0224540A1 (fr) 1987-06-10
WO1986007365A1 (fr) 1986-12-18
JPS63500515A (ja) 1988-02-25
FR2583049A1 (fr) 1986-12-12

Similar Documents

Publication Publication Date Title
NZ212895A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
IL86798A (en) 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
NZ222030A (en) Substituted imidazo-(5,4-g (3,1 benzoxaminone derivatives and pharmaceutical compositions
NZ224236A (en) Trans 3,4 pyridine derivatives and pharmaceutical compositions
NZ213461A (en) 1,4-dihyrdropyridine-3,5-dicarboxylic acid derivatives and pharmaceutical compositions
NZ192422A (en) Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
IL66999A0 (en) 1,4-naphthoquinone derivatives,their preparation and pharmaceutical and veterinary compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
OA08957A (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
NZ223865A (en) 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom
NZ220747A (en) Pharmaceutical compositions containing 1,3-oxazolidin-2- one derivatives
FR2583049B1 (fr) Produits resultant de la conjugaison d'un support macromoleculaire, d'un haptene et d'un muramyl-peptide par l'intermediaire d'un groupement substituant la partie saccharidique du muramyl-peptide et compositions selectivement immunogenes contenant ces produits
NZ225303A (en) 2,5 dialkyl-3-phenyl piperidine derivatives and pharmaceutical compositions
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
HUT37423A (en) Process for preparing 1,3-dioxolanyl derivatives and pharmaceutical compositions containing thereof
DE3268487D1 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives, their preparation and pharmaceutical compositions
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ237442A (en) 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions
NZ212915A (en) 9-oxo-15-alpha-hydroxy-16-(substituted) phenoxy-17,18,19,20-tetranorprosta-4,5,13(e)-triene prostaglandins and pharmaceutical compositions
NZ221626A (en) Dibenzo(a,d cycloheptene derivatives and pharmaceutical compositions
FR2601021B2 (fr) Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
ST Notification of lapse